Trump is reportedly trying to lure a German company working on coronavirus vaccine exclusively to the U.S.


No one can fault President Trump for wanting Americans to have access to a coronavirus vaccine in the future, but Germany isn't pleased with the way he's reportedly trying to do it.
Per Reuters, Germany's health ministry confirmed a report from German Newspaper Welt am Sonntag that said Trump has offered funds to lure biopharmaceutical company CureVac, which is working on developing a vaccine for the new virus, from Germany to the United States. Welt am Sonntag quoted an anonymous German official who said Trump would do anything to get a vaccine, "but only for the United States."
A German health ministry official, meanwhile, said Berlin wants to make sure vaccines and other substances that could be used to fight off the coronavirus are developed in Germany and Europe, as well. Above all, the hope is to avoid exclusivity.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"The exclusive sale of a possible vaccine to the USA must be prevented by all means," tweeted Karl Lauterbach, a professor of health economics epidemiology and German lawmaker, in response to the report. "Capitalism has limits."
There was no immediate comment from the U.S. embassy in Berlin, and CureVac declined to comment, but the company's CEO Daniel Menichella met with Trump, Vice Presidnet Mike Pence, and other members of the White House Coronavirus Task Force earlier this month.
CureVac is narrowing its field of vaccine candidates, and hopes to begin testing in June or July. Read more at Reuters.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
June 28 editorial cartoons
Cartoons Saturday's political cartoons include stupid wars, a critical media, and mask standards
-
Thai fish pie with crispy turmeric potatoes recipe
The Week Recommends Tasty twist on the Lancashire hot pot is given a golden glow
-
Palestine Action: protesters or terrorists?
Talking Point Damaging RAF equipment at Brize Norton blurs line between activism and sabotage, but proscription is a drastic step
-
'Tariff stacking' is creating problems for businesses
The Explainer Imports from China are the most heavily affected
-
Mortgages: The future of Fannie and Freddie
Feature Donald Trump wants to privatize two major mortgage companies, which could make mortgages more expensive
-
Economists fear US inflation data less reliable
speed read The Labor Department is collecting less data for its consumer price index due to staffing shortages
-
Pocket change: The demise of the penny
Feature The penny is being phased out as the Treasury plans to halt production by 2026
-
The UK-US trade deal: what was agreed?
In Depth Keir Starmer's calm handling of Donald Trump paid off, but deal remains more of a 'damage limitation exercise' than 'an unbridled triumph'
-
Crypto firm Coinbase hacked, faces SEC scrutiny
Speed Read The Securities and Exchange Commission has also been investigating whether Coinbase misstated its user numbers in past disclosures
-
Starbucks baristas strike over dress code
speed read The new uniform 'puts the burden on baristas' to buy new clothes, said a Starbucks Workers United union delegate
-
Trump vs. China: another tariff U-turn?
Today's Big Question Washington and Beijing make huge tariff cuts, as both sides seek 'exit ramp' from escalating trade war